Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    CALC - Chinese Alliance Against Lung Cancer Session

    • Type: Other Sessions
    • Track: Other Topics
    • Presentations: 15
    • Moderators:C. Bai
    • Coordinates: 10/27/2013, 07:30 - 12:00, Parkside Auditorium, Level 1
    • +

      Morning Tea and Chinese Poster Review

      09:25 - 09:55

      • Abstract

      No abstract available for this presentation

    • +

      CALC.01 - Welcome

      07:30 - 07:40  |  Author(s): C. Bai

      • Abstract

      Loading...

    • +

      CALC.02 - Keynote: Epidemiology and Burden of Smoking Related Diseases in China

      07:40 - 08:30  |  Author(s): C. Bai

      • Abstract

      Loading...

    • +

      CALC.03 - Pathogenesis and Pathology of Never Smoking Lung Cancer

      08:30 - 08:50  |  Author(s): A.F. Gazdar

      • Abstract

      Loading...

    • +

      CALC.04 - SBRT for Lung Cancer

      08:50 - 09:10  |  Author(s): M. Fan

      • Abstract

      Loading...

    • +

      CALC.05 - COPD and Lung Cancer

      09:10 - 09:25  |  Author(s): I.A. Yang

      • Abstract

      Loading...

    • +

      CALC.06 - Diagnosis of Lung Nodules by CT-Guided Lung Biopsy

      09:55 - 10:05  |  Author(s): Y. Song

      • Abstract

      Loading...

    • +

      CALC.07 - Molecular Signatures for the Accurate Classification of NSCLC and Neuroendocrine Tumors and Cell Lines

      10:05 - 10:25  |  Author(s): A.F. Gazdar

      • Abstract

      Loading...

    • +

      CALC.08 - Targeted Therapies for Adenocarcinoma, Now and Future

      10:25 - 10:45  |  Author(s): C. Zhou

      • Abstract

      Loading...

    • +

      CALC.09 - Targeted Therapies for SCC, Now and Future

      10:45 - 11:05  |  Author(s): T. Mok

      • Abstract

      No abstract available for this presentation

    • +

      CALC.10 - Second Line Treatment of NSCLC: Needed to Detect Driven Gene Mutation Status

      11:05 - 11:15  |  Author(s): B. Han

      • Abstract

      Loading...

    • +

      CALC.11 - MicroRNA Biomarkers in Lung Cancer

      11:15 - 11:25  |  Author(s): S. Lu

      • Abstract

      Loading...

    • +

      CALC.12 - IPF Caused by EGFR-TKIs in Asia

      11:25 - 11:35  |  Author(s): Q. Hong

      • Abstract

      Loading...

    • +

      CALC.13 - Novel Lung Cancer Plasma Immunoinflammatory Complexes

      11:35 - 11:45  |  Author(s): J. Hu

      • Abstract

      Loading...

    • +

      CALC.14 - Summary and Close, Thanks to CALC, Speakers and Sponsors

      11:45 - 12:00  |  Author(s): D.C. Lam

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P1.11 - Poster Session 1 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 45
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.11-021 - First-line erlotinib versus cisplatin/gemcitabine (GP) in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC): interim analyses from the phase 3, open-label, ENSURE study

      09:30 - 09:30  |  Author(s): Y. Wu

      • Abstract

      Loading...

    • +

      P1.11-044 - Progression-free survival is a poor surrogate endpoint for overall survival in the first line EGFR-TKI treatment in advanced non-small-cell lung cancer with EGFR mutation

      09:30 - 09:30  |  Author(s): R. Liao

      • Abstract

      Loading...

  • +

    P1.12 - Poster Session 1 - NSCLC Early Stage

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 23
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.12-008 - The effects of different preoperative brain survey strategy on the pathological stage I non-small cell lung cancer patients

      09:30 - 09:30  |  Author(s): C. Tu

      • Abstract

      Loading...

    • +

      P1.12-023 - Predictive factors of recurrence in lepidic predominant lung adenocarcinoma

      09:30 - 09:30  |  Author(s): J. Hung

      • Abstract

      Loading...

  • +

    P1.17 - Poster Session 1 - Bronchoscopy, Endoscopy

    • Type: Poster Session
    • Track: Pulmonology + Endoscopy/Pulmonary
    • Presentations: 10
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.17-001 - Transumbilical versus conventional thoracoscopic lung wedge resection: safety and efficacy in a canine survival model

      09:30 - 09:30  |  Author(s): Y. Liu

      • Abstract

      Loading...

  • +

    P1.24 - Poster Session 1 - Clinical Care

    • Type: Poster Session
    • Track: Supportive Care
    • Presentations: 53
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.24-007 - Long-term maintenance therapy with bevacizumab for Chinese advanced non-small cell lung cancer: a case report

      09:30 - 09:30  |  Author(s): Z. Liu

      • Abstract

      Loading...

  • +

    O01 - Prognostic and Predictive Biomarkers I

    • Type: Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 8
    • Moderators:T. Mitsudomi
    • Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Auditorium, Level 1
    • +

      O01.06 - Dynamic change in plasma EGFR mutation DNA in response to first line therapy for advanced stage non-small cell lung cancer (NSCLC)

      11:25 - 11:35  |  Author(s): T. Mok

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    O03 - NSCLC - Targeted Therapies I

    • Type: Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 8
    • Moderators:J. Ross
    • Coordinates: 10/28/2013, 10:30 - 12:00, Bayside Auditorium B, Level 1
    • +

      O03.05 - Activity of afatinib in uncommon epidermal growth factor receptor (EGFR) mutations: Findings from three trials of afatinib in EGFR mutation-positive lung cancer

      11:15 - 11:25  |  Author(s): J.C. Yang

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MS05 - Modern Management of Neuroendocrine Tumours

    • Type: Mini Symposia
    • Track: Surgery
    • Presentations: 5
    • Moderators:V. Rusch
    • Coordinates: 10/28/2013, 14:00 - 15:30, Bayside Gallery B, Level 1
  • +

    MS06 - Surgeons as Drivers of NSCLC Research

    • Type: Mini Symposia
    • Track: Surgery
    • Presentations: 5
    • Moderators:N. Alam
    • Coordinates: 10/28/2013, 14:00 - 15:30, Bayside 105, Level 1
  • +

    MO06 - NSCLC - Chemotherapy I

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 14
    • Moderators:R. Perez-Soler
    • Coordinates: 10/28/2013, 16:15 - 17:45, Parkside Ballroom A, Level 1
    • +

      MO06.13 - BEYOND: a randomized, double-blind, placebo-controlled, multicentre, phase III study of first-line carboplatin/paclitaxel (CP) plus bevacizumab (Bv) or placebo (Pl) in Chinese patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC)

      17:25 - 17:30  |  Author(s): C. Zhou

      • Abstract

      Loading...